Thomas N. Konatich
No más puestos en curso
Perfil
Thomas N.
Konatich was Vice President, Chief Financial Officer and Treasurer of SIGA Technologies, Inc. from April 1, 1998 to January 2009 and Secretary from June 29, 2001 to January 2009.
From 1993 to November 1996, he was Vice President and Chief Financial Officer of Seragen, Inc. From October 5, 2001 to July 2, 2004 and from May 1, 2006 to February 28, 2007, Mr. Konatich was an Acting Chief Executive Officer of SIGA Technologies and Chief Financial Officer and a Director of Innapharma, Inc. from November 1996 to March 1998.
He received an MBA from the Columbia Graduate School of Business.
Antiguos cargos conocidos de Thomas N. Konatich.
| Empresas | Cargo | Fin |
|---|---|---|
| SIGA TECHNOLOGIES, INC. | Director Financiero/CFO | 31/01/2009 |
Innapharma, Inc. (New York)
 Innapharma, Inc. (New York) Miscellaneous Commercial ServicesCommercial Services Part of TelMed, Inc., Innapharma, Inc. is a management consulting services company. The company is based in Suffern, NY. Innapharma, Inc. (New York) was acquired by TelMed, Inc. on June 26, 1996. | Director Financiero/CFO | 01/03/1998 |
Seragen, Inc.
 Seragen, Inc. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Seragen, Inc. develops drugs. The company is based in Westerly, RI. Seragen was acquired by Ligand Pharmaceuticals, Inc. on August 12, 1998 for $57.96 million. | Director Financiero/CFO | 01/11/1996 |
Formación de Thomas N. Konatich.
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SIGA TECHNOLOGIES, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Innapharma, Inc. (New York)
Innapharma, Inc. (New York) Miscellaneous Commercial ServicesCommercial Services Part of TelMed, Inc., Innapharma, Inc. is a management consulting services company. The company is based in Suffern, NY. Innapharma, Inc. (New York) was acquired by TelMed, Inc. on June 26, 1996. | Commercial Services |
Seragen, Inc.
Seragen, Inc. Pharmaceuticals: MajorHealth Technology Part of Ligand Pharmaceuticals, Inc., Seragen, Inc. develops drugs. The company is based in Westerly, RI. Seragen was acquired by Ligand Pharmaceuticals, Inc. on August 12, 1998 for $57.96 million. | Health Technology |
- Bolsa de valores
- Insiders
- Thomas N. Konatich
